Dr. Richard LeBlanc
Claim this profileGSK Investigational Site
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
2 reported clinical trials
7 drugs studied
Affiliated Hospitals
More about Richard LeBlanc
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Richard LeBlanc has experience with
- Belantamab Mafodotin
- Bortezomib
- Dexamethasone
- Lenalidomide
- Daratumumab And Hyaluronidase-fihj
- Mezagitamab
Breakdown of trials Richard LeBlanc has run
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard LeBlanc specialize in?
Richard LeBlanc focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Richard LeBlanc currently recruiting for clinical trials?
No, Richard LeBlanc is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Richard LeBlanc has studied deeply?
Yes, Richard LeBlanc has studied treatments such as Belantamab mafodotin, Bortezomib, Dexamethasone.
What is the best way to schedule an appointment with Richard LeBlanc?
Apply for one of the trials that Richard LeBlanc is conducting.
What is the office address of Richard LeBlanc?
The office of Richard LeBlanc is located at: GSK Investigational Site, Montreal, Quebec H1T 2M4 Canada. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.